Dermata Therapeutics, Inc (DRMA) Misses Q1 EPS by 48c
Tweet
Share
E-mailGet Alerts DRMA Hot Sheet
Join SI Premium – FREE
Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q1 EPS of ($0.48).
For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades AMD to buy with $575 price target ahead of Q4 earnings
- Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
- Anterix Inc. (ATEX) Tops Q4 EPS by 152c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
